StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)

Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –

IDEXX Laboratories price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

IDEXX Laboratories's price to book ratio was 34.4× on Nov 11, 2026, against 38.6× a year earlier. Over the last 5 years it ranged from 21.0× to 83.8×, with a median of 33.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202634.4×−0.3
2025Dec 31, 202534.7×+13.7
2024Dec 31, 202421.0×−14.6
2023Dec 29, 202335.5×−35.6
2022Dec 30, 202271.1×−2.9
2021Dec 31, 202174.1×−22.7
2020Dec 31, 202096.8×−14.0
2019Dec 31, 2019110.8×−92.5
2017Jan 31, 2017203.3×+8.4
2016Dec 30, 2016194.9×−17.2
2015Jul 31, 2015212.1×+178.6
2014Dec 31, 201433.5×+22.6
2013Dec 31, 201310.9×+2.4
2012Dec 31, 20128.5×+0.8
2011Dec 30, 20117.7×+0.1
2010Dec 31, 20107.6×–

More IDEXX Laboratories figures

See a number that looks wrong?